Geneva, May 20 -- International Clinical Trials Registry received information related to the study (ACTRN12625000428460) titled 'An Ascending, Single and Multiple Dose(s), Double-Blind, Randomized, Placebo Controlled Study Assessing the Safety, Tolerability, and Pharmacokinetics of Intravenous OV350 in Healthy Male and Female Participants' on May 8.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Randomised controlled trial
Primary Sponsor: Ovid Therapeutics Australia Pty Ltd
Condition:
Parkinson's Disease
Parkinson's Disease
Neurological - Parkinson's disease
Neurological - Dementias
Intervention:
The study will be a Phase 1, single-center, randomized, double-blind, placebo-controlled, inpatient study of t...